Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

16

Number of overlapping holdings

22.5%

% of CNCR's 71 holdings also in IDNA

34.8%

% of IDNA's 49 holdings also in CNCR

Overlap by Weight
Sector Drift (CNCR minus IDNA)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CNCR
Weight
in IDNA
Overlap
GERON CORP 3.8% 2.6% 2.6%
REVOLUTION MEDICINES, INC. 2.1% 4.6% 2.1%
BLUEPRINT MEDICINES CORP. 1.9% 1.8% 1.8%
REGENERON PHARMACEUTICALS 1.6% 4.3% 1.6%
MERCK & CO. INC. 1.5% 3.9% 1.5%

Position Highlights (Non-Overlapping Exposures)
CNCR Overweight Relative to IDNA
ENLIVEN THERAPEUTICS, INC. 2.8%
SUMMIT THERAPEUTICS INC 2.7%
ITEOS THERAPEUTICS, INC. 2.1%
ACRIVON THERAPEUTICS, INC. 2.1%
ERASCA, INC. 2.1%
NUVATION BIO INC CLASS A 2.0%
MERUS N.V. 1.8%
JANUX THERAPEUTICS, INC. 1.7%
AURA BIOSCIENCES INC 1.7%
PRELUDE THERAPEUTICS, INC. 1.7%
CNCR Underweight Relative to IDNA
SAREPTA THERAPEUTICS INC -4.8%
ROCHE HOLDING LTD -4.7%
GILEAD SCIENCES INC -4.5%
INCYTE CORP -4.5%
SANOFI-AVENTIS -4.1%
TAKEDA PHARMACEUTICAL CO LTD -4.0%
GENMAB A/S -3.9%
GSK PLC -3.8%
BEIGENE, LTD. -3.7%
TWIST BIOSCIENCE CORP. -3.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY